Results 151 to 160 of about 4,254 (200)
Some of the next articles are maybe not open access.
DIPHOSPHONATES AND PAINFUL FEET
Australian and New Zealand Journal of Medicine, 1983Abstract: Localised foot pain occurred in four patients with Paget's disease of bone or myositis ossificans who were treated with disodium etidronate (EHDP) in a dose of 10 to 20 mg/kg body weight/day for four to six months. There was localised tenderness and sometimes slight swelling at the painful areas.
R A, Evans, D, MacDonald
openaire +2 more sources
DIPHOSPHONATES IN THE TREATMENT OF MYOSITIS OSSIFICANS
Lancet, The, 1969A Donath, M D Francis, R Preisig
exaly +3 more sources
[Treatment with diphosphonates].
La Clinica terapeutica, 1980---
ZAVAGLI, Giorgio +2 more
openaire +2 more sources
Uranyl Diphosphonates with Pillared Structures
Inorganic Chemistry, 2009A series of five uranyl diphosphonates with pillared and canted pillared structures have been prepared and characterized. These compounds are constructed from UO(6) tetragonal bipyramids and UO(7) pentagonal bipyramids that are bridged by the diphosphonate anions. All of these compounds fluoresce at room temperature.
Pius O, Adelani +1 more
openaire +2 more sources
Diphosphonate Treatment of Calcinosis Universalis
New England Journal of Medicine, 1971CALCINOSIS universalis is a condition characterized by progressive accumulation of amorphous calcium phosphate and crystalline hydroxyapatite in subcutaneous lesions. The etiology is not known. Numerous modes of therapy have been proposed, including increased dietary phosphate, a diet low in calcium and high in phosphorus, a ketogenic diet, infusions ...
R L, Cram +3 more
openaire +2 more sources
DIPHOSPHONATES AND PAGET'S DISEASE OF BONE
The Lancet, 1971Abstract The diphosphonate, CH 3 C(OH)(PO 3 HNa) 2 (disodium etidronate), has been given at a daily oral dose of 20 mg. per kg. body-weight to 4 patients with biochemically active Paget's disease. The increased alkaline phosphatase in plasma and the increased hydroxyproline in plasma and urine fell steadily to about half their initial value after ...
R, Smith, R G, Russell, M, Bishop
openaire +2 more sources
Diphosphates and diphosphonates in polyoxometalate chemistry
Chemical Society Reviews, 2012In the wide area of polyoxometalate (POM) chemistry, diphosphate/diphosphonate-based POMs represent a more recent area of study. However, in this short time it has emerged to become very dynamic, as shown by the wide variety of compounds reported. Ever since the discovery of the first polyoxotungstate framework constructed from diphosph(on)ate ligands,
Abhishek, Banerjee +3 more
openaire +2 more sources
Diphosphonate Treatment of Paget's Disease
Clinical Orthopaedics and Related Research, 1976Ethane-1-hydroxy-1, 1-diphosphonate (EHDP) was administered in a dose of 20 mg/kg/d to 21 patients with symptomatic Paget's disease. All patients were treated for 6 months and then followed for an additional 6 months. There was a striking decline in serum alkaline phosphatase and urinary hydroxy-proline excretion observed after 3 months of therapy ...
G A, Finerman +3 more
openaire +2 more sources
The Orthopaedic Implications of Diphosphonate Therapy
American Academy of Orthopaedic Surgeon, 2010Diphosphonates are among the many commonly prescribed drugs for osteoporosis management. These synthetic analogues of physiologically occurring inorganic pyrophosphate bind to the hydroxyapatite crystals of bone. Diphosphonates act by decreasing the amount of osteoclast-mediated bone resorption by inducing apoptosis and disrupting the mevalonate ...
Michael J, Weaver +2 more
openaire +2 more sources